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Purpose 
The purpose of this study was to investigate the speaking fundamental frequency (SFF) in pre- and postmenopausal women with and without 
hormone therapy (HT) and with low and high BMI.  
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Voice Assessment 
The mean SFF of 
connected speech was 
measured using Real-
Time Pitch (Model 5121 
V3.1.6) program from 
Computerized Speech 
Lab from Kay. 
 
Background 
The voices of middle-aged women are subject to a combination of aging and menopausal transition. The menopause ends the reproductive period 
and is characterized by a decrease of the female sex hormones estrogen and progesterone. The hormone balance and the ratio of estrogen and 
progesterone to androgens changes and the influence of androgens becomes more important in the female body. In the postmenopause, ovarian 
contribution of estrogen is negligible, and adipose tissue becomes the main source of estrogen production . Hormone therapy (HT) has a long-
standing tradition for the treatment of menopausal complaints. It compensates for the drop in endogenous estrogen and or progesterone levels in 
the postmenopause. It is known that sex hormones influences the female voice. When studying voice in middle-aged women a distinction should be 
made between premenopausal women, postmenopausal with HT and postmenopausal women without HT, with low and high BMI. 
Discussion 
The SFF of premenopausal women with low BMI was compared with the SFF of premenopausal women with high BMI, postmenopausal women with HT 
and low BMI, postmenopausal women with HT and high BMI, postmenopausal women without HT and with low BMI and postmenopausal women without 
HT and with high BMI. The results of this study show that the SFF of premenopausal women with low BMI (mean: 188.3Hz) only differed from the SFF of 
postmenopausal women without HT and with low BMI. (mean: 174.5Hz). The mean difference in SFF between these two groups was 14 Hz. This 
difference of 14Hz corresponds with 1.32 semitones or with 7.6% [188.8Hz-174.5Hz)/188.8Hz]. 
The results of this study suggest that the menopause lowers the voice with approximately 14Hz and that HT and adipose tissue (high BMI) might 
counteracts the menopausal drop in SFF.  
    LSD 
    p-value 
premenopausal women low BMI premenopausal women high BMI 0.837 
postmenopausal women with HT low BMI 0.934 
postmenopausal women with HT high BMI 0.937 
postmenopausal women without HT low BMI 0.010 
  postmenopausal women without HT high BMI 0.428 
n SFF ANCOVA 
    mean SD p-value 
premenopausal women low BMI 22 188.3 17.6 
premenopausal women high BMI 13 189.6 15.1 
postmenopausal women with HT low BMI 35 188.7 18.2 
postmenopausal women with HT high BMI 19 187.8 22.6 
postmenopausal women without HT low BMI 28 174.5 17.8 
postmenopausal women without HT high BMI 12 183.0 11.3 0.016 
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 Subjects               
n 
Age 
(years) BMI 
time of 
menopause 
(years) 
    mean SD mean SD mean SD 
premenopausal women low BMI (<25) 22 48.5 2.3 21.6 1.9 
premenopausal women high BMI (> 25) 13 48.1 2.3 29.0 4.4 
postmenopausal women with HT low BMI (<25) 35 57.5 5.0 22.4 1.9 7.6 4.5 
postmenopausal women with HT high BMI (> 25) 19 56.7 4.1 27.3 1.8 7.1 3.5 
postmenopausal women without HT low BMI (< 25) 28 58.5 5.5 22.5 1.7 8.2 6.6 
postmenopausal women without HT high BMI (> 25) 12 59.4 5.4 28.0 2.2 11.2 5.4 
